A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF SIRAVYADHA AND VIRECHANA IN HYPERLIPIDEMIA

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF SIRAVYADHA AND VIRECHANA IN HYPERLIPIDEMIA - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084076

Enrollment

Registered

2025-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects diagnosed with Hyperlipidemia. 2)Subjects aged between 30-60 years, irrespective of gender. 3)Subjects who are fit for Siravyadha and Virechana Karma.

Exclusion criteria

Exclusion criteria: Subjects with uncontrolled Diabetes Mellitus, Hypertension and Cardiovascular diseases, renal disorders, bleeding disorders, which may interfere with the procedure. HIV and HBsAg positive Pregnancy and lactating women.

Design outcomes

Primary

Measure	Time frame
Lipid profile will be assesed after treatment (After 15 days in Group A and after samsarjana in group B). Again lipid profile will be assesed during follow up peroidTimepoint: Lipid profile will be assesed after treatment (After 15 days in Group A and after samsarjana in group B). Again lipid profile will be assesed during follow up peroid	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDR PAVITHRA BJ

GOVERNMENT AYURVEDA MEDICAL COLLEGE

anantdesai30@gmail.com9481193570

Outcome results